Financials ZoomMed Inc.

Equities

ZMD.H

CA98977R1038

Advanced Medical Equipment & Technology

End-of-day quote Toronto S.E. 06:00:00 2018-10-03 pm EDT 5-day change 1st Jan Change
0.015 CAD -.--% Intraday chart for ZoomMed Inc. -.--% -.--%

Valuation

Fiscal Period: May 2021 2022 2023
Capitalization 1 2.034 2.034 2.034
Enterprise Value (EV) 1 0.9744 1.873 2.427
P/E ratio 0.69 x -1.66 x 11.6 x
Yield - - -
Capitalization / Revenue 0.61 x 182 x 156 x
EV / Revenue 0.29 x 168 x 186 x
EV / EBITDA 0.33 x -16.5 x -11.1 x
EV / FCF - -3,432,029 x -2,777,788 x
FCF Yield - -0% -0%
Price to Book 3.66 x -3.03 x -4.09 x
Nbr of stocks (in thousands) 135,591 135,591 135,591
Reference price 2 0.0150 0.0150 0.0150
Announcement Date 6/27/23 6/27/23 9/28/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: May 2021 2022 2023
Net sales 1 3.326 0.0111 0.013
EBITDA 1 2.988 -0.1133 -0.2192
EBIT 1 2.984 -0.116 -0.2201
Operating Margin 89.71% -1,040.81% -1,691.62%
Earnings before Tax (EBT) 1 2.926 -1.227 0.1754
Net income 1 2.926 -1.227 0.1754
Net margin 87.98% -11,007.75% 1,348.23%
EPS 2 0.0216 -0.009051 0.001293
Free Cash Flow - -0.5458 -0.8735
FCF margin - -4,895.72% -6,712.83%
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 6/27/23 6/27/23 9/28/23
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: May 2021 2022 2023
Net Debt 1 - - 0.39
Net Cash position 1 1.06 0.16 -
Leverage (Debt/EBITDA) - - -1.791 x
Free Cash Flow - -0.55 -0.87
ROE (net income / shareholders' equity) - 2,093% -30%
ROA (Net income/ Total Assets) - -3.8% -34%
Assets 1 - 32.29 -0.516
Book Value Per Share 2 0 -0 -0
Cash Flow per Share 2 0 0 0
Capex 1 0 - -
Capex / Sales 0.05% - -
Announcement Date 6/27/23 6/27/23 9/28/23
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. ZMD.H Stock
  4. Financials ZoomMed Inc.